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Abstract
Aging is associated with a progressive loss of muscle mass, increased adiposity and fibrosis that leads to sarcopenia. At the
molecular level, muscle aging is known to alter the expression of a variety of genes but very little is known about the
molecular effectors involved. SRF (Serum Response Factor) is a crucial transcription factor for muscle-specific gene
expression and for post-natal skeletal muscle growth. To assess its role in adult skeletal muscle physiology, we developed a
post-mitotic myofiber-specific and tamoxifen-inducible SRF knockout model. Five months after SRF loss, no obvious muscle
phenotype was observed suggesting that SRF is not crucial for myofiber maintenance. However, mutant mice progressively
developed IIB myofiber-specific atrophy accompanied by a metabolic switch towards a more oxidative phenotype, muscular
lipid accumulation, sarcomere disorganization and fibrosis. After injury, mutant muscles exhibited an altered regeneration
process, showing smaller regenerated fibers and persistent fibrosis. All of these features are strongly reminiscent of
abnormalities encountered in aging skeletal muscle. Interestingly, we also observed an important age associated decrease
in SRF expression in mice and human muscles. Altogether, these results suggest that a naturally occurring SRF down-
regulation precedes and contributes to the muscle aging process. Indeed, triggering SRF loss in the muscles of mutant mice
results in an accelerated aging process.
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Introduction
Skeletal muscle accounts for about 40% of the mass of the adult
human body and is essential for maintaining and moving the
skeleton, for breathing and for thermoregulation. Skeletal muscle
is also one of the most metabolically active tissues in the body. The
effects of aging on skeletal muscle include gradual loss of muscle
mass, decline in muscle quality and functional properties. The
decline in muscle quality is characterized by the presence of
intramuscular fat, tissue fibrosis and a decreased regenerative
potential. These age-related modifications in skeletal muscle,
which have also been called sarcopenia, can be particularly severe
and can affect both quality of life and lifespan of patients [1]. In
order to counteract these modifications both in muscle structure
and function, it is essential to understand the mechanisms involved
in the maintenance of muscle mass and quality.
The regulation of muscle mass depends on a fine balance
between protein synthesis and protein degradation which are
controlled by different growth factors and signalling pathways [2].
For instance, activation of PI3Kinase/Akt/mTOR signalling
downstream of IGF-1 increases protein content whereas activation
of the ubiquitin-proteasome pathways through Atrogin1 and Murf1
stimulates protein degradation [3]. Whilst the mechanisms involved
in skeletal muscle homeostasis have been rather well described,
those involved in the age-related decline in muscle quality have not
yet been fully elucidated. Age-related wasting and decreased
regeneration potential of muscles have been associated to the
decline in satellite cell function with age rather than to their
number. Components of the micro-environment, or ‘‘niche’’, which
supports satellite cell activation, may vary with age. These
components include: molecular signals expressed or secreted by
the myofiber, basal lamina structure, products secreted by local
interstitial cells (such as connective tissue, micro-vasculature, neural
and immune system cellular components) and systemic factors [4].
Indeed, recent data hasdemonstrated the importanceof endocrine/
paracrine factors and Wnt pathways in age-related changes in
muscle [5] as well as in more general aging processes [6].
At the molecular level, muscle aging is known to alter the
expression of a variety of genes within the myofibers but very little is
known about their molecular effectors [7–9]. Our recent findings
have emphasized the role played by Serum Response Factor (SRF)
in controlling post-natal muscle growth and transcription of locally
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accretion to growing myofibers [10]. SRF is a member of the
MADS family of transcription factors that is produced in
particularly large amounts in all muscles. Via binding to CArG
box regulatory elements, SRF controls several extracellular stimuli-
regulatedgenesimportantforcell growth,survivaland migration,as
well as muscle-specific genes. Moreover, several recent data -
including ours- have demonstrated that SRF plays a key role in
regulating the expression of many genes encoding muscle
cytoskeletal and sarcomeric proteins including those for actins
[10,11]. SRF driven transcription of specific gene promoters can be
regulated by different mechanisms, including modulating the level
of SRF expression, SRF phosphorylation, nature and number of
CArG boxes in the target gene, RhoA-mediated alterations in the
cytoskeleton and association of SRF with different context or cell-
specific co-factors. Several data suggest that SRF could be
important when muscle mechanical loading is perturbed [12,13].
For example SRF transcriptional activity is up-regulated by
biomechanical stimuli via pathways involving integrin signalling
[14]. SRF could thus play a central role in modulating gene
expression to adapt muscle contractility to physiological demands.
In order to investigate SRF function in skeletal muscle growth
and physiology, we created a model of targeted invalidation of SRF
using the Cre-LoxPsystem [10].However,theearlyandprogressive
evolution of the muscle phenotype, the fragility and the high degree
of lethality of these mutant mice made it difficult to investigate the
function of SRF in fully mature muscle physiology. By crossing mice
homozygous for SRF floxed alleles (S
f/S
f) with HSA-Cre-ER
T2
transgenic mice [15] that express a tamoxifen (TAM) dependent
Cre recombinase,exclusivelyinpost-mitoticmyofibers,we obtained
a mouse model in which it is now possible to trigger at will the onset
of SRF ablation in skeletal myofibers.
Here we show that mutant mice in which SRF is selectively
ablated in adult post-mitotic myofibers develop a broad spectrum
of alterations similar to those which have been described in age-
advanced skeletal muscles. Thus, the age-related decrease in SRF
that we observed in both mice and human muscles might
contribute to muscle aging.
Materials and Methods
Generation of Mutant Mice
Mice homozygous for SRF floxed alleles [16] (abbreviated to S
f/
S
f) and HSA-Cre-ER
T2 transgenic mice [15] have been described
elsewhere. These two mouse strains were backcrossed onto a
C57BL/6N genetic background for 7 generations prior to
experimental analysis and then crossed to generate double-
transgenic mice HSA-Cre-ER
T2:S
f/+. Subsequent breeding of
HSA-Cre-ER
T2:S
f/+ and S
f/S
f mice generated HSA-Cre-ER
T2:S
f/S
f
pre-mutant mice. Mice were genotyped by PCR, using DNA
extracted from tail biopsies. In all experiments, groups of 2 months
old male pre-mutant (HSA-Cre-ER
T2:S
f/S
f) and sex- and aged-
matched control (S
f/S
f) mice were given daily intraperitoneal
TAM (1 mg per day; Sigma) injections for 5 consecutive days.
Cre-mediated excision of SRF floxed alleles was detected as
previously described [16]. All studies were conducted in
accordance with European guidelines for the care and use of
laboratory animals and were approved by the institutional animal
care and use committee.
Human Skeletal Muscle Tissues
Muscle biopsies were obtained via the french ‘‘Banque de
Tissue pour la Recherche de l’AFM’’ (BTR-AFM) according to
the French legislation on ethical rules. In general this material was
surgical waste from orthopedic surgery. All biopsies had received
patient consent and were anonymous. Samples were snap frozen
in liquid nitrogen and stored at 280uC until use.
Induction of Cardiotoxin-Induced Muscle Injury
Muscle regeneration was induced as described previously [17]. In
brief, TAM-injected control and mutant mice were anaesthetised with
Isoflurane (0.75 to 1.0% in oxygen) and received a single injection of
cardiotoxin (CTX) (50 mla t1 2mM, intramuscular injection, Latoxan)
into the Tibialis Anterior (TA) muscle. After 21 days in vivo muscle
strength was measured the mice were killed, the TA muscle was
removed and subsequently processed for histological analysis.
Measurement of in vivo Muscle Strength
In vivo muscle strength was measured in order to evaluate the
recovery from injury. Twenty-one days after muscle injury,
animals were anaesthetised (pentobarbital, 60 mg/kg) and the in
situ isometric contractile properties of the injured TA muscles were
studied. In order to do this the distal tendon was attached to an
isometric transducer (Harvard Bioscience, Les Ulis, France) using
a silk ligature. The body temperature was maintained at about
37uC by means of heating lamps. The nerves innervating the
muscles (proximally crushed) were stimulated with a bipolar silver
electrode using a supramaximal square wave pulse of 0.1 ms
duration. Measurements were made at L0 (length at which
maximal tension was obtained during the twitch). Maximal tetanic
force (P0; stimulation frequency of 75–143 Hz) was recorded and
analysed on a personal microcomputer, using PowerLab system
and Chart 4 software (ADInstruments, Paris, France). Once the
contractile measurements had been made, the animals were killed
with an overdose of pentobarbital. Muscles were then weighed,
frozen in liquid nitrogen respectively precooled in isopentane and
stored at 280uC until histological analyses were carried out.
Muscle Histology, Immunohistochemistry, and
Morphometric Measurements
All experiments involved the evaluation of control and mutant
littermates and were conducted on at least 5 mice per group.
Hindlimb muscles from 2 to 15 months old mice were removed and
embedded in Tragacanth Gum, frozen in isopentane cooled in
liquid nitrogen, and sectioned in a microtome cryostat (Leica). For
the assessment of tissue morphology or visualization of fibrosis, 7-
mm-thick transverse sections of the TA muscles were stained
respectively with hematoxylin and eosin (H&E) and Sirius red and
examined under a light microscope. Lipid accumulation was
detected in the TA muscle fibers using Oil Red-O staining following
fixation in 3% paraformaldehyde according to Koopman et al. [18],
nuclei were visualised by counterstaining with DAPI (Molecular
Probes).Forfibertype analysis,serialsectionsoftheplantarismuscle
were processed either with a set of antibodies against the various
myosin heavy chain (MyHC) isoforms, as previously described [19]
or stained for the presence of SDH enzyme activity. Fiber area was
analysed by incubating plantaris muscle sections with mouse anti-
dystrophin Dys2 antibody (Novocastra) and staining them with
Hoechst [20]. Between 600 and 1000 myofibers were analyzed per
muscle. For each muscle, the distribution of fiber cross-sectional
area (CSA) was determined by using Metamorph, version 2.56,
software. For SRF immunodetection, paraffin-embedded longitu-
dinal TA muscle sections were incubated with a 1:200 dilution of a
rabbit polyclonal antibody directed against the carboxy-terminal
domain of SRF (G-20, Santa Cruz Biotechnology), as described
elsewhere[16].TAsectionswerealsostained withmodifiedGomori
trichrome to reveal tubular aggregates as red spots inside fibers in
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fibers per muscle were analysed (n=3 muscles for control and
mutant) and their frequencywas determinedbyplottingthe number
of tubular aggregates per individual fiber versus the percentage of
fibers with tubular aggregates.
Images were taken using a Nikon Statif Eclipse E600
microscope with 206 or 406 magnification, 1.4-0.7 NA PL-
APO objectives, a DXM1200 cooled CCD camera (Nikon) and
ACT-1 (Universal Imaging).
Electron Microscopy
Electron microscopy was performed on Plantaris muscles from
mutant and control adult mice 13 months after TAM injection, as
previously described [21].
Western Blot Analysis
Western blotting was performed on various mouse muscles and
human muscle biopsies as previously described [16]. Membranes
were blotted overnight at 4uC with anti-SRF G-20 (1:200), anti-
glyceraldehyde-3-phosphate dehydrogenase (anti-GAPDH;
1:2000) (Santa Cruz Biotechnology) and anti a-Tubulin (1:2000)
antibodies (Sigma). The precursor and mature forms of Sterol
Regulatory Element Binding Protein-1c (SREBP-1c) were detected
using a monoclonal antibody raised against the N-terminus (amino
acids 301–407) of human SREBP-1 (NeoMarkers), and Fatty Acid
Synthase polyclonal antibody (FAS) was a gift from I. Dugail
(INSERM U465, France). After washes in TBS-T, membranes
were incubated with horseradish peroxidase-conjugated goat anti-
mouse or anti-rabbit secondary antibody (Pierce, Rockford, USA)
and then revealed using the enhanced chemiluminescence system
(Supersignal; Pierce). Signals were scanned and quantified using a
ChemiGenius Apparatus (Syngene).
Quantitative RT-PCR Analysis
Total RNA was extracted from Gastrocnemius muscles using a
commercial kit (RNeasy, Qiagen) following the manufacturer’s
protocol. cDNA was synthesized from 2 mg of RNA using
Moloney Murine Leukemia Virus reverse transcriptase (Invitro-
gen) and random hexamers (Promega). Quantitative PCR analysis
was performed using a Light Cycler (Roche) according to the
manufacturer’s instructions using a SYBR Green I kit (Roche).
Briefly, the final volume of 10 ml contained 16 ng of reverse-
transcribed total RNA, 10 mM of primer mix, 6 ml of the Reaction
Mix SYBR Green. Reactions were carried out in capillaries
(Roche) with 40 cycles. The comparative threshold cycle (CT)
method was used to calculate the relative concentrations. This
method involved obtaining CT values for the transcripts of interest
normalizing to the housekeeping gene Cyclophilin and comparing
the relative differences between control and mutant samples.
Primer sequences are available on request.
Statistical Analysis
Results are expressed as means6standard errors of the means
(SEM). The significance of differences between means was assessed
with Student’s t test. P values of ,0.05 were considered statistically
significant.
Results
Efficient Tamoxifen-Induced Loss of SRF in Skeletal Muscle
HSA-Cre-ER
T2:S
f/S
f pre-mutant mice were healthy and fertile
for months without any sign of muscle alteration. Two months old
male HSA-Cre-ER
T2:S
f/S
f pre-mutant mice and S
f/S
f control
littermates were TAM-injected, and hereafter are referred to as
mutants and controls, respectively. Following TAM injection, Cre-
mediated excision of S
f floxed alleles was found to be restricted to
skeletal muscle (data not shown) and within nine days after the first
injection resulted in an 80% down regulation of the SRF mRNA
level in mutant muscles (Fig 1C). The decrease in SRF levels was
found to be similar in different muscles. Consistent with these
findings, western blotting showed that SRF protein levels were
80% lower in mutant compared to control skeletal muscles
(Fig. 1A) and in mutants the majority of the myonuclei were no
longer immunostained for SRF (Fig 1B). The efficient loss of SRF-
dependent gene expression in mutant muscles was also confirmed
by a concomitant and major reduction in the mRNA levels of
known SRF target genes, such as skeletal (60%) and cardiac (60%) a-
actin (Figure 1C) as well as muscle creatine kinase to a lesser extent
(data not shown). More importantly, the loss of expression of both
SRF and actin persisted with time, as illustrated by the analysis of
the mutant muscles 5 months after TAM-injection (Fig 1C).
Figure 1. Validation of the skeletal muscle-specific SRF KO
model after TAM injection. (A) Immunoblot analysis of protein
extracts from control (Cnt) and mutant (Mut) muscles 9 days after TAM
injection using an anti-SRF antibody. Anti-GAPDH is used as a loading
control. (B) Immunostaining of longitudinal sections from control and
mutant TA muscles with the anti-SRF antibody 9 days after TAM
injection. Bars: 50 mm. (C) Quantitative real-time PCR was performed on
RNAs prepared from gastrocnemius muscles of control (white) and
mutant (black) mice 9 days (9 d.) and 5 months (5 m.) after TAM
injection (n=4 for controls and mutants at each time). Mean expression
levels for SRF, Skeletal and Cardiac a-actin mRNAs were normalized
using Cyclophilin transcript as a reference.
doi:10.1371/journal.pone.0003910.g001
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In spite of an important down-regulation of skeletal and cardiac a-
actin transcripts and in the absence of any detectable compensation
by other actin isoforms, such as smooth muscle a-actin, c and b actins
(data not shown), the mutant mice remained healthy several
months after TAM injection when kept in standard conditions.
When analyzed 5 months after TAM injection (7 months old
mice), no obvious difference could be observed between controls
and mutants in body weight, in myofiber CSA or in oxidative/
glycolytic muscle fiber type patterning, as illustrated in table 1.
However, 13 months after TAM injection (15 months old mice),
mutant muscles displayed signs of atrophy. At this time, SRF
expression was still 60% lower in mutant muscles, indicating a
limited contribution of the recruitment of new nuclei derived from
satellite cells, which express SRF, to the adult myofibers (Fig 2A).
As illustrated in Fig 2B, no difference was observed in myofiber
CSA distribution between controls and mutants 5 months after
TAM injection (Fig. 2B). In contrast, 13 months after TAM
injection, the fiber size distribution was altered in mutants, with
the vast majority of the mutant muscle fibers having a CSA
between 500 and 1000 mm2, whereas the mean myofibers CSA
for control muscle fibers was between 1500 and 2000 mm2
(Fig. 2C). The CSA of the muscle fibers depends on their
contractile and energy metabolism status. In the plantaris muscle
which is mainly composed of fibers that express MyHC-IIA and -
IIB (80%), fast/oxidative type IIA fibers have a smaller CSA than
fast/glycolytic IIB fibers. Therefore, we investigated whether the
distribution of oxidative/glycolytic myofiber subtypes was modi-
fied in mutant muscles, using antibodies specific to MyHC-IIA and
-IIB isoforms. No significant differences were observed 5 months
after TAM injection (table 1). In contrast, 13 months after TAM
injection, immunostaining showed that the mutant Plantaris
muscle contained fewer MyHC-IIB myofibers (38% versus 54%
in control) and more MyHC-IIA myofibers (43% versus 27% in
control) as illustrated in Fig. 2D and Table 1. SDH staining was
performed in order to assess whether the MyHC fiber type
modification was accompanied by a metabolic switch from
glycolytic to oxidative metabolism. In agreement with MyHC
typing data, we observed an increase in the number of myofibers
with high SDH staining in muscles lacking SRF since 13 months
(Fig. 2D; Table 1). Moreover, measurement of the mean CSA of
the various myofiber subtypes revealed a specific atrophy of
MyHC-IIB fibers in mutant muscle (Fig. 2E). Hence, both a
specific MyHC-IIB fiber atrophy and a switch towards a more
oxidative phenotype seemed to account for the atrophy observed
in mutant muscles. This phenotype is strongly reminiscent of what
is observed in aged muscles, with IIB myofibers being more prone
to age related muscle atrophy [22]. Another classical sign of
skeletal muscle aging is an increase in tissue fibrosis [5]. We
therefore investigated the presence of fibrosis by Sirius red staining
in 15 months old control and mutant mice. As illustrated in
Fig. 3A, mutant muscles exhibited endomysial fibrosis, whereas
such an accumulation of fibrotic tissue has never been observed in
control muscles at the same age.
Fat Accumulation in Mutant Muscles
Age-related changes in skeletal muscle are also characterised by
an increased fat content [1]. We investigated a possible alteration
in the lipid content of mutant muscles in comparison to aged-
matched control muscles by using Oil Red O staining that
highlights the accumulation of neutral lipids. As illustrated in
Figure 3B, Oil Red-O positive droplets were abundant in 15
months old mutant muscles, whereas only a weak staining was
observed in age-matched control muscles (Fig. 3B). Muscles
lacking SRF accumulated both extracellular and intramyocellular
lipids. We have previously shown that intramyocellular lipids
resulted mainly from de novo lipogenesis (lipid synthesis from
glucose) in rodent muscle fibers [23]. To determine whether
intramyocelullar lipid accumulation resulted from lipogenesis in
mutant muscle, we measured the protein levels of two actors of
lipogenesis, the Sterol Regulatory Element Binding Protein-1c
(SREBP-1c), a key lipogenic transcription factor that has been
shown to regulate the transcription of genes involved in fatty acid
metabolism, and Fatty Acid Synthase (FAS), one of the SREBP-1c
targets. At the molecular level, lipid accumulation was shown 8
months after TAM injection (10 months old mice) in mutant
muscles to be correlated with an up-regulation of the transcrip-
tionnally active form of SREBP-1c protein (Fig. 3C). This was
correlated with an up-regulation of FAS in the mutant muscles,
whereas no increase was observed in TAM-injected age-matched
controls. The increase in SREBP-1c expression was not accom-
panied with an up-regulation of SREBP-1c mRNA, thus excluding
a direct transcriptional control by SRF (data not shown). These
results suggest that lipogenesis is activated in mutant muscles and
can already be detected 8 months after TAM injection, which is
not the case in age-matched control muscles.
Altered Sarcomere Ultrastructure in Mutant Muscles
Since skeletal and cardiac a-actin transcription was found to be
profoundly decreased in mutant muscles, we investigated the
consequences of SRF loss on muscle structure. Ultrastructural
analysis revealed changes in the structure of the 15 months old
mutant myofibers. Whereas age-matched control muscle displayed
regularly oriented actin/myosin filaments and well structured Z-
disks, mutant muscles displayed sarcomere unit disorganisation
(Fig. 4A, left panel). In addition, muscles of male mutant mice
exhibited tubular aggregates that were detected 8 months after
TAM injection (data not shown) and increased both in number
and size 13 months after TAM injection (Fig. 4A, right panel).
These tubular aggregates appeared as accumulations of densely
packed tubules arising from sarcoplasmic reticulum. The accu-
mulation of such aggregates has been described to be an age-
related phenomenon in skeletal muscle of male mice [24]. To
quantify these tubular aggregates, skeletal muscle sections from 15
months old control and mutant male mice (13 months after TAM
injection) were stained with modified Gomori’s trichrome that
reveals tubular aggregates as red spots inside fibers (Fig. 4B).
Figure 4C shows the distribution of the number of tubular
aggregates per fiber in 15 months old control and mutant muscles.
Only 1,6% of the fibers contained aggregates in control muscle,
Table 1. Plantaris muscle characteristics from control and
mutant mice 5 and 13 months after TAM injection.
7-months-old 15-months-old
Controls Mutants Controls Mutants
% MyHC IIA 3565,4 3761,2 27,5610,2 4463,2 *
% MyHC IIB 4364,6 3866,8 5469,9 3865,3 *
% SDH+ 4262,2 44,562,2 30,465,3 55,266,9 *
Body weight (g) 22,561,9 2060,6 33,463,6 32,363,6
*P,0,05 over controls 13 months after TAM injection.
doi:10.1371/journal.pone.0003910.t001
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these had two or more aggregates per fiber.
These ultrastructural alterations combined with the myofibers
atrophy were associated with a tendency towards a decrease in
muscle strength 13 months after TAM injection. However, the
individual variability and the small number of mice available for
these studies did not allow us to observe a statistically significant
reduction in strength but the mutants all displayed a lower
maximal tetanic force by comparison with age-matched control
(not shown).
Figure 2. Progressive atrophy of MyHC-IIB fibers and metabolic switch in SRF deficient muscles. (A) Quantitative real-time PCR was
performed on RNAs prepared from gastrocnemius muscles of control (white) and mutant (black) mice 5 months (5 m.) and 13 months (13 m.) after
TAM injection (n=4). Mean expression levels for SRF mRNAs was normalized using Cyclophilin transcripts as a reference. (B, C) Frequency histogram
showing distributions of muscle fiber CSA in control (white) and mutant (black) plantaris muscles 5 (B) and 13 (C) months after TAM injection (n=4
for control and mutant at each time; 600 fibers were analysed for each muscle) (D) Immunostaining analysis using MyHC-IIA,-IIB antibody (left and
middle panels) and SDH staining (right panel) of transversal sections of control and mutant plantaris muscles 13 months after TAM injection. Bars:
50 mm. (E) Mean myofiber CSA of MyHC-IIA or -IIB expressing myofibers from control (white) and mutant (black) 5 and 13 months after TAM injection
(n=4, 600 myofibers were measured for each muscle). *P,0.05 over controls 13 months after TAM injection.
doi:10.1371/journal.pone.0003910.g002
Figure 3. Fibrosis accumulation and alteration of lipid metabolism in SRF deficient muscles. (A) Sirius Red staining of transversal sections
of control and mutant TA muscles 13 months after TAM injection. Bars: 50 mm. (B) Oil Red O staining of transversal sections of control and mutant TA
muscles 13 months after TAM injection. Nuclei are counter-stained with DAPI. Bars: 50 mm. (C) Immunoblot analysis of protein extracts from control
(Cnt) and mutant (Mut) muscles 8 months after TAM injection using anti-SRF, anti-SREBP1c and anti-FAS antibodies. Anti-GAPDH is used as a loading
control.
doi:10.1371/journal.pone.0003910.g003
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To evaluate the role of SRF in muscle regeneration, we
compared the muscle histological characteristics of 4 months old
mutant and control mice after CTX injury. Muscle regeneration
involves satellite cell activation and recruitment for fusion with
damaged myofibers or for the production of new muscle fibers. As
satellite cells of mutant muscles do not express the Cre-ER
T2
recombinase, control and mutant mice were injected every three
days with TAM during the regeneration process to avoid possible
re-expression of SRF in myofibers after satellite cell recruitment.
Before regeneration, analysis of H&E-stained sections demon-
strated no visible differences between the two types of mice
regarding the histology of TA muscle (data not shown). Twenty-
one days after injury, while a complete regeneration was observed
in control muscles, characterized by centrally located, nuclei
mutant muscles displayed increased interstitial spaces and smaller
regenerated myofibers (Fig. 5A and B). Such altered regeneration
was confirmed by comparing the regenerated myofiber CSA at
day 21 post-injury. As presented in Fig. 5B, the size distribution of
regenerated myofibers CSA of mutants is decreased as compared
with regenerated control myofibers. To evaluate whether the
enlarged interstitial spaces observed in the injured muscle from
mutant mice were associated with the accumulation of fibrotic
tissue, we performed Sirius Red staining. Regenerated mutant
muscle displayed an important increase in fibrosis (Fig. 5C) that
persists at least 3 months after CTX injury (not shown). To
evaluate whether histological differences between the regenerated
muscles from control and mutant mice were associated with a
difference in the functional recovery from injury, maximal tetanic
force was measured before and 21 days after CTX (Fig. 5D). After
CTX injury, recovery of strength was 80% complete in control but
only 20% in mutant mice. Maximal force production was related
to muscle weight. Therefore, muscle mass was also measured. The
mass of injured TA was also reduced by 40% in mutant mice
compared with controls (Fig. 5E).
Evolution of SRF Expression as a Function of Age in
Mouse and Human Skeletal Muscle
The overall phenotype of mutant mice at steady state and
during regeneration is strongly reminiscent of age-related skeletal
muscle abnormalities. These results prompted us to analyse the
expression of SRF in skeletal muscles isolated from control mice at
various ages. A progressive and important decrease in SRF protein
expression, up to a 70% down-regulation at 15 months of age,
could be observed in skeletal muscle with age (Figure 6A). This
SRF down-regulation did not occur at the transcriptional level as
illustrated by Real Time PCR (Fig. 6B, left). However, the
functionality of SRF was impaired as confirmed by a 30% down-
regulation of skeletal a-actin transcripts and an 80% down-
regulation of cardiac a-actin transcripts with age in 15 months old
control muscles (Fig. 6B). In humans as in mice, skeletal muscle
regeneration is impaired with age [25] and there is an increase in
fat within and between the muscle fibers [1]. We thus wanted to
know whether SRF was also down-regulated in the skeletal muscle
of elderly humans. Western blots of muscle biopsies from humans
at different ages showed that whereas SRF protein was abundantly
expressed in skeletal muscles of young subjects (24 years old) as the
age of the subjects increased (80 and 83 years old) we observed a
progressive decrease in the expression of SRF (Figure 6C).
Discussion
In the present study, we have investigated the role of SRF in the
physiology of adult skeletal muscle by using an inducible Cre-
mediated SRF gene disruption strategy that allows us to trigger the
onset of SRF loss only within mature post-mitotic myofibers [15].
In contrast to the drastic phenotype observed in previous
skeletal muscle-specific SRF KO models affecting growing
myofibers [10,26], inducing SRF loss in adult myofibers did not
produce an overt phenotype within the first months after
triggering SRF disruption. While our data show that SRF remains
a major regulator of skeletal and cardiac a-actin transcription in the
context of adult skeletal muscle, they also suggest that SRF is much
less crucial for the maintenance of fully differentiated myofibers
than for pre and peri-natal muscle growth. However, most
notably, we show here that with time, mutant skeletal muscles
develop a wide spectrum of alterations including atrophy, fibrosis,
lipid accumulation and a perturbed regeneration. In combination,
all these features are characteristic of aged skeletal muscle [1],
suggesting that triggering SRF loss in adult myofibers leads to a
premature aging process. Most interestingly, we also observed
decreased SRF levels in the skeletal muscle of aged mice and
humans, suggesting that a naturally occurring decrease in SRF
expression could contribute to the muscle phenotype observed
during the aging process and in sarcopenia.
An Inducible Model of SRF Ablation that Mimics an
Accelerated Skeletal Muscle Aging
By using Cre transgenes with different temporal expression
patterns during muscle development, our laboratory and others
have observed that SRF may have different functions towards its
known target genes according to the developmental stage of the
skeletal muscle [10,26]. Such differences in SRF transcriptional
activity have also been observed in embryonic versus adult heart
[16,27]. Since SRF seems to be able to shift between different gene
expression programs according to the physiological state, of the
muscle. The ability to inactivate SRF at a specific and controlled
time point may help us to understand its different specific
functions. TAM-dependent activation of the Cre-ER
T2 led to an
efficient, but not complete deletion of the SRF gene in skeletal
muscle fibers, as revealed by the presence of a small proportion of
immunostained nuclei for SRF in mutant myofibers. This was
confirmed by the fact that, about 20% of SRF transcripts were
detected by quantitative RT-PCR in TAM-injected mutants
whereas, using the same approach, very few SRF transcripts could
be detected in our previous constitutive muscle-specific SRF KO
model in which the Cre was driven by the same human skeletal a-
actin promoter (data not shown) [10]. Such residual amounts of
SRF might be sufficient to activate a certain sub-set of SRF-
Figure 4. Impaired sarcomere ultrastructure in SRF deficient muscles. (A) Representative electron micrographs of longitudinal sections of
control and mutant Plantaris muscles. Well-structured sarcomere units are observed in control myofibers 13 months after TAM injection. Major
changes to the ultrastructure in the male mutant Plantaris muscle are illustrated by sarcomere unit disorganisation (left panel) with the presence of
tubular aggregates (right panel). Bars: 0.2 mm. (B) Modified Gomori trichrome staining of transversal sections of control and mutant Tibialis muscles
13 months after TAM injection. Arrowhead indicates the presence of tubular aggregates in the mutant muscle. Bars: 50 mm. (C) Quantification of the
frequency of tubular aggregate formation in control (white) and mutant (black) TA muscles 13 months after TAM injection (n=3 for control and
mutant; 700 fibers were analysed for each muscle). The frequency was determined by plotting the number of tubular aggregates per individual fiber
versus the percentage of fibers with tubular aggregates. *P,0.05 over control.
doi:10.1371/journal.pone.0003910.g004
Role for SRF in Muscle Aging
PLoS ONE | www.plosone.org 8 December 2008 | Volume 3 | Issue 12 | e3910Role for SRF in Muscle Aging
PLoS ONE | www.plosone.org 9 December 2008 | Volume 3 | Issue 12 | e3910dependent genes but not others. This could explain why the
transcription of the skeletal a-actin gene that contains 4 CArG boxes
and is a major SRF target [28] is down-regulated by 60%, whereas
the transcription of the IGF-1 gene with one active CArG box [10]
was not affected in this model (data not shown). Another possibility
is that SRF is needed for IGF-1 transcription in the context of the
growing myofiber, but not in the adult. A number of studies have
shown that there is an age-related decline in the level of muscle
IGF-1 during sarcopenia. Aging muscle has also been associated
with an attenuation of the ability of exercise to induce IGF-1 [29].
Moreover, an over-expression of the mIGF1 isoform in mouse
muscle has been shown to protect against age-related muscle
alterations [30]. In contrast, other data shows that there is no local
down-regulation of IGF-1 mRNA in aged muscle and that, the
most sarcopenic individuals showed higher local expression of IGF-
1 mRNA [31]. Accordingly, in our model, we can exclude the
Figure 5. Impaired regeneration in SRF deficient muscles. (A) Representative H&E-stained of transversal sections of TA muscles from control
and mutant mice 21 days after CTX injection. Bars: 50 mm. (B) Frequency histogram showing distributions of myofibers CSA in control (white) and
mutant (black) regenerated TA muscles 21 days after CTX injection (n=5; 1000 myofibers were analysed for each muscle). (C) Sirius Red staining of
transversal section of control and mutant TA muscle 21 days after CTX injection. Bars: 50 mm. (D, E) Maximal tetanic force, PO (D) and TA weight (E)
were measured before and 21 days after CTX injection from control (white) and mutants (black) mice. (n=5) *P,0.05 over control 21 days after CTX.
doi:10.1371/journal.pone.0003910.g005
Figure 6. Age-dependant down-regulation of SRF expression in skeletal muscle of mice and human. (A) Immunoblot analysis of protein
extracts from 2, 10 and 15 month-old control muscles using anti-SRF antibody. Anti-a-Tubulin is used as a loading control. (B) Quantitative real-time
PCR was performed on RNAs prepared from Gastrocnemius muscles of control mice 2 (white) and 15 (grey) months old. Mean expression levels for
SRF, Skeletal and Cardiac a-actin mRNAs was normalized using Cyclophilin transcript as reference. (n=4). *P,0.05 over control 2 month-old. (C)
Immunoblot analysis of protein extracts from human skeletal muscle (24, 55, 80 and 83 years old) using anti-SRF antibody. Ponceau staining is used as
a loading control.
doi:10.1371/journal.pone.0003910.g006
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the accelerated aging process that is observed. Our data
demonstrate that this inducible model of SRF ablation mimics
what occurs naturally and progressively during normal mouse
muscle aging. Moreover, we show that once an 80% SRF loss has
been induced in 2 months old mice, the installation of the
phenotype is very progressive. The phenotype begins to be
observed at 8 months after TAM injection (lipid accumulation,
tubular aggregates) but all of the alterations, associated with
premature aging, can only be clearly observed at 13 months after
TAM injections. In 15 months old control muscles, in spite of a
significant and natural decrease in SRF protein (70%) and a
concomitant down-regulation of the target actin genes, we could
not observe a particular muscle phenotype. Similar but milder
muscle alterations to those observed in mutant mice could only be
observed in very old mice (25 months old; data not shown).
Altogether these data strongly suggest that the natural and
progressive decrease of SRF could contribute to some of the
age-related muscle alterations and that our model of inducible
SRF down expression reproduce an accelerated aging process.
Mutant Muscles Develop a Late Fiber-Type Switch and
Selective IIB-Myofibers Atrophy
In steady state conditions, the residual levels of SRF and actin
transcripts seem to be sufficient for the maintenance of normal
mature muscle fibers for at least 5 months after TAM injection.
However, with time the loss of SRF resulted in a global myofiber
atrophy as evidenced by the alteration of the fiber size distribution.
Since oxidative myofibers have a smaller CSA, this decrease in
fiber size may be due at least in part to the overall switch towards
more oxidative fibers that we observed in mutant muscles. This
switch in fiber types is associated with an increase of the IIA/IIB
fiber ratio which is also in line with an increased oxidative
metabolism. This result is in accordance with what we previously
observed in the non-inducible muscle-specific SRF KO [10] and
data from the literature showing that SRF activates the fast/
glycolytic fiber-specific MyHC IIB gene promoter and represses
the fast/oxidative fiber-specific MyHC IIA promoter [32]. Dy/dy
dystrophic mice that have reduced muscle SRF content [33] also
exhibit decreased MyHC IIB levels [34,35]. Although we cannot
exclude that the slow/oxidative phenotype of mutants could be
related to a physiological adaptation of muscles to the premature
aging, our data support a role for SRF in maintaining the
expression of the MyHC IIB gene.
Mutant muscles also develop a selective atrophy of fast MyHC
IIB expressing myofibers. Interestingly, it has been reported that
the age-related decrease in skeletal muscle mass observed in
humans is also caused by a selective atrophy of type II fibres [22].
As the starting SRF level is lower in fast/glycolytic muscles than in
slow/oxidative ones [13], we propose that the down-regulation of
SRF in IIB myofibers through normal aging or TAM-induced in
mutant mice have earlier impact than in other myofibers types,
thus leading to specific atrophy.
The decreased expression of the skeletal and cardiac a-actin that
occurred in mutant muscle and to a lesser extent in aging muscles
could also contribute to the atrophy and to the alterations in
sarcomere organization that are observed in mutants. Skeletal a-
actin comprises about 90% of the muscle actin in adult mouse
skeletal muscle and corresponding knockout mice die during the
perinatal period from abnormalities in skeletal muscle growth and
force generation [36]. In mutant muscles, the sarcomeric
disorganisation was associated with the presence of tubular
aggregates that are another sign of muscle senescence.
A Possible Role for SRF in Controlling Muscle Lipid
Content
The phenotype of sarcopenia includes a loss of muscle mass with
an increase in intramuscular fat and connective tissue [22,37]. In
muscles triggered for SRF loss, we observed an important lipid
accumulation. We could show that this increased muscle lipid
content is due at least in part to de novo lipogenesis as the mature
form of SREBP1-c is up-regulated and its target gene FAS is
activated. Most interestingly, several data obtained in different
cellular models have already pointed to an inverse correlation
between SRF activity and the activation of an adipogenic
program. Indeed, the nuclear localisation of SRF is repressed
during both senescence and adipocyte differentiation of murine
3T3 mesenchymal stem cells [38]. The anticancer drug distamycin
A, which induces the adipocyte differentiation of 10T1/2
pluripotential cells, selectively inhibits the binding of SRF to
DNA [39]. Mechanical stretch, that is known to activate SRF
expression [13], was shown to inhibit C2C12 myoblast-to-
adipocyte differentiation [40]. Altogether, our in vivo results
strongly support an active role for SRF in inhibiting an
‘‘adipogenic’’ program within myofibers. When SRF loss is
triggered, such an inhibition would be alleviated, leading to the
up-regulation of the mature form of SREBP1-c. However, SRF
does not act directly on SREBP1-c transcription, as we did not
observe any up-regulation of SREBP1-c transcripts in mutant
muscles. The mechanisms linking SRF to the inhibition of lipid
synthesis remains to be investigated.
Role of SRF in Regeneration and Fibrosis
The regenerative potential of skeletal muscle declines with age
and this impairment is associated with an increase in tissue fibrosis
[5]. In the previous non-inducible muscle-specific SRF KO, we
observed that the mutant muscle fails to regenerate. In this model,
before injury, muscle lacking SRF presented a myopathy
characterized by a drastic myofiber hypotrophy and impaired
maturation [10]. In the new model of inducible SRF loss described
here, we show that, 2 months after TAM injection, whereas
mutant myofibers lacking SRF appear normal, the regeneration
process is also altered, with the presence of smaller regenerated
myofibers, persistent endomysial fibrosis and reduced strength.
These results emphasize a direct role for SRF during regeneration.
In this model, as in the previous one, satellite cells are not targeted
by the SRF disruption and their intrinsic properties are preserved
[10]. Thus, alterations in the growth of regenerated muscle fibers
in mutant mice most probably stems from a modified satellite cell
niche. Such modification could result from an altered myofiber
signalling or environment coming from mutant myofibers. The
important fibrosis observed in mutant muscles either with aging in
mutant muscles or after regeneration suggests that the lack of SRF
in myofibers also contributes to modify the environment in a way
favouring the appearance and the maintenance of fibrosis.
Consistent with this finding, myofibers from transgenic mice
expressing a dominant negative form of the MRTF-A SRF co-
factor that suppresses SRF activity, also displayed extensive fibrosis
[26].
The critical role of age-related changes in the satellite cell niche
and the resulting impairment of muscle regeneration has been
recently underlined [4]. In this scope, the myofiber itself
constitutes one of the main niche components and our model in
which it is the only mutated component strongly supports a major
role for alterations coming from the myofibers in the age-related
process. The particular role of SRF within the myofiber for
maintaining a proper satellite cell environment and/or profile of
secreted myokines remains to be characterized [41].
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The phenotype of premature aging observed in muscles triggered
forSRFlossdemonstratesthat thesignificant decreaseintheamount
ofSRF proteinthatwe observed with timeincontrol skeletalmuscles
could at least in part contribute to the aged-muscle phenotype.
Importantly, we could show that SRF expression is also impaired
with aging in humans. In accordance with our results, very recently,
Sakuma et al. reported a decrease in both SRF and MRTF-A with
aging, in the skeletal muscle of mice [42]. Moreover, the expression
of SRF targets such as actin has been shown to be down-regulated
during aging in rats [43] and humans (cardiac a-actin but also egr1 and
c-fos) [7]. Thus, the maintenance of SRF expression seems to be
critical to ensure a proper response of skeletal muscle to damaging
insults and to prevent age-related abnormalities. Interestingly, the
fine tuning of SRF expression and activity has also been shown to be
very important for the function of the cardiac and smooth muscle
tissues.Inthesetissues,age-relatedalterationsinSRFlevelswerealso
associated to pathological states. Hence, in contrast to what we
observed inskeletalmuscle, SRF expression is increased inthe hearts
of old rats and mice in the basal conditions [44,45]. This age-related
increase correlates with a cardiac pathogenic phenotype that is
alleviated when SRF activity is down-regulated through the
expression of a mutant SRF protein [44]. Consistent with these
finding, cardiac a-actin expression is up-regulated in old myocardium
[46]. An increased expression of SRF and cognate target genes in
vascular smooth muscle cells seems to account for the arterial
hypercontratility observed in Alzheimer disease [47]. Hence the
modulation of SRF expression, function and localisation seems to be
very important in maintaining the integrity of muscle tissues. The
aging process would alter this tissue-specific fine tuning of SRF
expression and activity, leading in turn to the progressive
development of further muscle alterations and sarcopenia in human
skeletal muscles. Resistance training is currently the most effective
known strategy to combat sarcopenia. It is interesting to note that
SRF plays a central role in transducing mechanical signals from cell
membranes to skeletal fiber nuclei via pathways involving integrin
b1, RhoA and Focal Adhesion kinase [14,48]. Moreover, mechan-
ical activity is known to increase SRF expression [12,13].
Altogether, our data show that the model of inducible muscle-
specific SRF KO that we describe here could represent a key
genetic tool for studies designed to elucidate the mechanisms
involved in impaired skeletal muscle maintenance in human aging.
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